Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Medtronic
Dow
McKinsey
Fuji
Covington
Boehringer Ingelheim
Healthtrust

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017703

« Back to Dashboard

NDA 017703 describes CYLERT, which is a drug marketed by Abbott and is included in two NDAs. Additional details are available on the CYLERT profile page.

The generic ingredient in CYLERT is pemoline. There are seven drug master file entries for this compound. Additional details are available on the pemoline profile page.
Summary for 017703
Tradename:CYLERT
Applicant:Abbott
Ingredient:pemoline
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017703

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, CHEWABLE;ORALStrength37.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKinsey
Boehringer Ingelheim
Chubb
Queensland Health
Dow
Johnson and Johnson
US Department of Justice
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.